MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Early cortical atrophy is related to depression in Parkinson’s disease

    E. Backman, L. Saari, R. Parkkola, J. Lötjönen, M. Gardberg, V. Kaasinen (Turku, Finland)

    Objective: To investigate depression in relation to medial temporal lobe atrophy (MTA), global cortical atrophy (GCA) and white matter hyperintensities (WMH) in neuropathologically confirmed patients…
  • 2023 International Congress

    Quantifying the impact of sensory tricks on the overall severity of cervical dystonia

    A. Mahajan, D. Gonzalez, G. Stebbins, C. Comella (Chicago, USA)

    Objective: To quantify the impact of sensory trick on botulinum toxin dose and treatment outcomes in cervical dystonia (CD) Background: Sensory tricks are voluntary maneuvers…
  • 2023 International Congress

    Patient perspectives on symptoms and functional impacts to inform a digital assessment of Parkinson’s disease

    B. Fehlmann, A. Thomann, E. Davies, J. Twiss, C. Romano, D. Whalley, M. Mayorga, C. Levy, F. Lipsmeier, W. Popp, T. Kustermann, H. Svoboda, T. Nikolcheva, D. Trundell, M. Lindemann, K. Taylor (demuro)

    Objective: The aim of this study is to map patients’ reports of functional limitations and impacts of Parkinson’s disease (PD) to motor signs captured with…
  • 2023 International Congress

    Orthostatic hypotension and frailty

    A. Ovchynnykova, E. Trufanov (Kyiv, Ukraine)

    Objective: to investigate the relationship between functional class of orthostatic hypotension (FC OH) and frailty index (FI). Background: frailty syndrome (FS) as well as orthostatic…
  • 2023 International Congress

    Assessment of non-motor symptoms of Parkinson’s disease after the repeated courses of the autologous stem cell therapy

    V. Chyzhyk, A. Boika, V. Ponomarev (Minsk, Belarus)

    Objective: To evaluate the influence of the second course of the cell therapy on the dynamics of the non-motor symptoms in patients with PD 6…
  • 2023 International Congress

    Hemiparkinsonism secondary to a cerebral cavernous malformation (CCM)

    M. González Sánchez, B. De-La-Casa Fages, JR. Pérez Sánchez, A. Contreras Chicote, S. Secades García, E. Luque Buzo, Y. Fernández Bullido, G. Lafuente Gómez, O. Mateo Sierra, FJ. Grandas Pérez (Madrid, Spain)

    Objective: To describe a case of secondary parkinsonism of unhabitual cause and complex treatment. Background: Secondary parkinsonism constitutes approximately 15% of all parkinsonism cases in…
  • 2023 International Congress

    Moving beyond trial and error: a strategy for anatomically informed contact selection in subthalamic deep brain stimulation for Parkinson’s disease.

    GA. Brandt, V. Stopic, C. Hennen, JN. Strelow, JN. Petry-Schmelzer, JC. Baldermann, MT. Barbe, V. Visser-Vandevalle, TA. Dembek (Cologne, Germany)

    Objective: In this study we aimed to investigate and compare the utility of conventional DBS programming strategies and anatomically informed approaches predicting long term motor…
  • 2023 International Congress

    Utilization pattern and factors associated with amantadine use in Parkinson’s disease (PD) of the French NS-Park cohort

    M. Fabbri, S. Tessier, V. Rousseau, JC. Corvol, A. Sommet, F. Tubach, Y. de Rycke, N. Bertille, Y. Selvarasa, S. Carvalho, C. Brefel-Courbon, F. Ory-Magne, O. Rascol (Blagnac, France)

    Objective: To assess amantadine use in the French NS-Park cohort and factors associated with its prescription Background: Amantadine, a unique dopamine/glutamate drug, is approved worldwide…
  • 2023 International Congress

    Effects and neural mechanisms of training involving rhythmic auditory stimulation on upper-limb movements in patients with Parkinson’s disease

    W. Fan, K. Fong, S. Wang (Hong Kong, China)

    Objective: This study is to examine effects and neural mechanisms of training involving rhythmic auditory stimulation on upper-limb movements in patients with Parkinson’s disease (PD).…
  • 2023 International Congress

    Asymptomatic Gaucher disease presented as Parkinsonism in 61 years old patient.

    E. Basha, E. Ranxha, J. Tana (Tirana, Albania)

    Objective: Gaucher disease is an inherited disease caused by a mutation in the glucocerebrosidase gene, causing visceral, hematologic, and skeletal involvement. [1] [2] We report…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24475 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley